NO20015114L - Adipocyttkomplementbeslektet proteinhomolog zacrp2 - Google Patents

Adipocyttkomplementbeslektet proteinhomolog zacrp2

Info

Publication number
NO20015114L
NO20015114L NO20015114A NO20015114A NO20015114L NO 20015114 L NO20015114 L NO 20015114L NO 20015114 A NO20015114 A NO 20015114A NO 20015114 A NO20015114 A NO 20015114A NO 20015114 L NO20015114 L NO 20015114L
Authority
NO
Norway
Prior art keywords
zacrp2
related protein
protein homologue
complement related
adipocyte complement
Prior art date
Application number
NO20015114A
Other languages
English (en)
Other versions
NO20015114D0 (no
Inventor
Christopher S Piddington
Paul D Bishop
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NO20015114D0 publication Critical patent/NO20015114D0/no
Publication of NO20015114L publication Critical patent/NO20015114L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Foreliggende oppfinnelse gjelder polynukleotid- og polypeptidmolekyler for zacrp2, et nytt medlem av familien av proteiner som bærer et kollagen- lignende domene og et Clq-domene. Polypeptidene og polynukleotidene som koder for dem, deltar i dimerisering eller oligomerisering og kan anvendes for undersøkelser derav. Foreliggende oppfinnelse omfatter også antistoffer mot zacrp2-polypeptidene.
NO20015114A 1999-04-20 2001-10-19 Adipocyttkomplementbeslektet proteinhomolog zacrp2 NO20015114L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29507299A 1999-04-20 1999-04-20
PCT/US2000/010452 WO2000063376A1 (en) 1999-04-20 2000-04-19 Adipocyte complement related protein homolog zacrp2

Publications (2)

Publication Number Publication Date
NO20015114D0 NO20015114D0 (no) 2001-10-19
NO20015114L true NO20015114L (no) 2001-12-19

Family

ID=23136091

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015114A NO20015114L (no) 1999-04-20 2001-10-19 Adipocyttkomplementbeslektet proteinhomolog zacrp2

Country Status (9)

Country Link
EP (1) EP1171599A1 (no)
JP (1) JP2002541846A (no)
AU (1) AU4468600A (no)
CA (1) CA2370602A1 (no)
IL (1) IL146011A0 (no)
MX (1) MXPA01010540A (no)
NO (1) NO20015114L (no)
WO (1) WO2000063376A1 (no)
ZA (1) ZA200108438B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6716965B2 (en) 2000-11-29 2004-04-06 Zymogenetics, Inc. Adipocyte complement related protein zacrp13
US20020155546A1 (en) * 2000-11-29 2002-10-24 Fox Brian A. Adipocyte complement related protein ZACRP12

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
AU758074B2 (en) * 1998-04-29 2003-03-13 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
WO1999059618A1 (en) * 1998-05-21 1999-11-25 Smithkline Beecham Corporation Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)

Also Published As

Publication number Publication date
AU4468600A (en) 2000-11-02
CA2370602A1 (en) 2000-10-26
EP1171599A1 (en) 2002-01-16
ZA200108438B (en) 2002-08-28
NO20015114D0 (no) 2001-10-19
WO2000063376A1 (en) 2000-10-26
IL146011A0 (en) 2002-07-25
JP2002541846A (ja) 2002-12-10
MXPA01010540A (es) 2002-06-04

Similar Documents

Publication Publication Date Title
ATE324443T1 (de) Für adipozyten spezifische protein homologe
NO20000215L (no) Adipocyttspesifikke proteinhomologer
ATE318905T1 (de) Homologe des tie-rezeptortyrosinekinase liganden
NO960767L (no) Protocadherinproteiner og deres anvendelse
NO973933D0 (no) Vaskulær endotelvekstfaktor B
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
HRP20050024A2 (en) Pegylated t20 polypeptide
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
DK258789D0 (da) Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet
ES8704207A1 (es) Procedimiento para preparar una molecula de adn
NO20015114L (no) Adipocyttkomplementbeslektet proteinhomolog zacrp2
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
DK316984A (da) Fremgangsmaade til oploesning af peptider
DE3871318D1 (de) Oligomerisation von olefinen.
DK1387854T3 (da) SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf
WO2002008257A3 (en) Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
DK312787D0 (da) Polypeptider, fremgangsmaade til deres fremstilling, dna som koder for polypeptiderne, vektorer indeholdende saadanne gensekvenser og laegemidler indeholdende polypeptiderne
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
WO2002059282A3 (en) Adipocyte complement related protein zacrp13
NO891926D0 (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
DE69000909D1 (de) Transportables brueckenteil zur ueberwindung von graeben.
DE69000596D1 (de) Katalytische zusammensetzung und deren verwendung zur oligomerisation von monoolefinen.
WO2002044373A3 (en) Adipocyte complement related protein zacrp12
ATE408687T1 (de) Semaphorin polypeptide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application